Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be at least 18 years old when you start treatment with cemiplimab
- You must have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC), confirmed through a lab test of a tissue or cell sample
- Your doctor must have already decided, as part of your normal care, to prescribe you a treatment plan that includes cemiplimab
- You must be able to understand and fill out questionnaires related to the study
- You must be able to give written consent to take part and must sign a consent form before any study activities begin
Who may not be able to join:
- You have already received cemiplimab before joining the study
- You have an autoimmune disease (where the immune system attacks the body) that is not well controlled
- You have a medical reason why cemiplimab would not be safe for you, based on the official prescribing guidelines
- You are currently taking part in another clinical study involving an experimental drug or procedure
- You have memory, thinking, or other health difficulties that, in your doctor's opinion, would make it hard for you to complete the study questionnaires
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.